Quantum-Si (Quantum-Si) Cash, Cash Equivalents, Marketable Securities : $235.43 Mil (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Quantum-Si Cash, Cash Equivalents, Marketable Securities?

Quantum-Si's quarterly cash, cash equivalents, marketable securities declined from Sep. 2023 ($274.63 Mil) to Dec. 2023 ($257.74 Mil) but then stayed the same from Dec. 2023 ($257.74 Mil) to Mar. 2024 ($235.43 Mil).

Quantum-Si's annual cash, cash equivalents, marketable securities declined from Dec. 2021 ($471.30 Mil) to Dec. 2022 ($351.31 Mil) and declined from Dec. 2022 ($351.31 Mil) to Dec. 2023 ($257.74 Mil).

Quantum-Si Cash, Cash Equivalents, Marketable Securities Historical Data

The historical data trend for Quantum-Si's Cash, Cash Equivalents, Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Quantum-Si Cash, Cash Equivalents, Marketable Securities Chart

Quantum-Si Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Cash, Cash Equivalents, Marketable Securities

36.91

471.30

351.31

257.74

Quantum-Si Quarterly Data
	Dec19	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Cash, Cash Equivalents, Marketable Securities	Get a 7-Day Free Trial												322.09	297.19	274.63	257.74	235.43

Quantum-Si Cash, Cash Equivalents, Marketable Securities Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Quantum-Si (NAS:QSI) Cash, Cash Equivalents, Marketable Securities Explanation

Marketable securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.

Quantum-Si Cash, Cash Equivalents, Marketable Securities Related Terms

Thank you for viewing the detailed overview of Quantum-Si's Cash, Cash Equivalents, Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

Quantum-Si (Quantum-Si) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Quantum-Si Inc (NAS:QSI) » Definitions » Cash, Cash Equivalents, Marketable Securities

Comparable Companies

Traded in Other Exchanges

N/A

Address

530 Old Whitfield Street, Guilford, CT, USA

Website

https://www.quantum-si.com

Quantum-Si Inc is focused on revolutionizing the growing field of proteomics. The company's suite of technologies is powered by a first-of-its-kind semiconductor chip designed to enable single-molecule next-generation protein sequencing and genomics, and digitize proteomic research in order to advance drug discovery and diagnostics beyond DNA sequencing.

Executives

Amir Jafri	director	C/O QUANTUM-SI INCORPORATED, 29 BUSINESS PARK DR., BRANFORD CT 06405
John P. Kenny	director	3471 RIVER HILLS DRIVE, CINCINNATI OH 45244
Jeffry R. Keyes	officer: Chief Financial Officer	13950 STOWE DRIVE, POWAY CA 92064-8803
Scott Mendel	director	5964 LA PLACE COURT, ADDRESS 2, CARLSBAD CA 92008
Christian Lapointe	officer: General Counsel & Corp. Secr.	C/O QUANTUM-SI INCORPORATED, 530 OLD WHITFIELD STREET, GUILFORD CT 06437
Grace Johnston	officer: Chief Commercial Officer	C/O QUANTUM-SI INCORPORATED, 530 OLD WHITFIELD STREET, GUILFORD CT 06437
Kevin Rakin	director, officer: Chairman and CEO	36 CHURCH LANE, WESTPORT CT 06880
Jeffrey Alan Hawkins	director, officer: Chief Executive Officer	5964 LA PLACE COURT, CARLSBAD CA 92008
Vikram Bajaj	director	600 MONTGOMERY STREET, SUITE 4500, SAN FRANCISCO CA 94111
Jonathan M Rothberg	director, 10 percent owner	C/O BUTTERFLY NETWORK, INC., 530 OLD WHITFIELD ST., GUILFORD CT 06437
Matthew Dyer	officer: Chief Business Officer	C/O QUANTUM-SI INCORPORATED, 530 OLD WHITFIELD STREET, GUILFORD CT 06437
Michael P Mckenna	officer: President and COO	C/O CURAGEN CORP, 555 LONG WHARF DR. 11TH FL., NEW HAVEN CT 06511
Patrick Schneider	officer: President and COO	C/O QUANTUM-SI INCORPORATED, 530 OLD WHITFIELD STREET, GUILFORD CT 06437
John Viii Stark	director, officer: Chief Executive Officer	C/O QUANTUM-SI INCORPORATED, 530 OLD WHITFIELD STREET, GUILFORD CT 06437
2012 Jmr Trust Common Llc	10 percent owner	C/O QUANTUM-SI INCORPORATED, 530 OLD WHITFIELD STREET, GUILFORD CT 06437